Theriva Biologics (TOVX) Other Accumulated Expenses (2018 - 2021)

Theriva Biologics (TOVX) has reported Other Accumulated Expenses for 4 consecutive years, with $2000.0 the latest figure, recorded in Q2 2021.

• In Q2 2021, Other Accumulated Expenses changed N/A year-over-year to $2000.0; the TTM figure through Jun 2021 stood at $2000.0 (changed N/A YoY), while the FY2019 annual figure was $1000.0, down 91.67% from the prior year.
• Other Accumulated Expenses was little changed at $2000.0 in Q2 2021 per TOVX's latest filing, from $2000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $12000.0 in Q4 2018 and bottomed at $1000.0 in Q4 2019.
• Historically, Other Accumulated Expenses has averaged $4571.4 across 4 years, with a median of $2000.0 in 2021.
• Annual changes were most pronounced in 2019 — Other Accumulated Expenses tumbled 91.67% — and 2020, when it slumped 83.33%.
• Theriva Biologics' Other Accumulated Expenses stood at $12000.0 in 2018, then sank by 91.67% to $1000.0 in 2019, then changed by 0.0% to $1000.0 in 2020, then surged by 100.0% to $2000.0 in 2021.
• Business Quant data shows TOVX's Other Accumulated Expenses at $2000.0 in Q2 2021, $2000.0 in Q1 2021, and $1000.0 in Q3 2020.